Crossject Société Anonyme (EPA:ALCJ)
1.132
-0.178 (-13.59%)
Apr 1, 2025, 12:42 PM CET
Crossject Société Anonyme Revenue
In the year 2024, Crossject Société Anonyme had annual revenue of 13.23M EUR with 241.61% growth. Crossject Société Anonyme had revenue of 1.58M in the half year ending June 30, 2024, a decrease of -46.75%.
Revenue
13.23M
Revenue Growth
+241.61%
P/S Ratio
n/a
Revenue / Employee
38.82K
Employees
106
Market Cap
62.57M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 13.23M | 9.36M | 241.61% |
Dec 31, 2023 | 3.87M | -3.19M | -45.18% |
Dec 31, 2022 | 7.06M | 583.00K | 9.00% |
Dec 31, 2021 | 6.48M | 1.64M | 33.77% |
Dec 31, 2020 | 4.84M | -58.27K | -1.19% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sanofi | 44.29B |
EssilorLuxottica Société anonyme | 26.51B |
Sartorius Stedim Biotech | 2.78B |
bioMérieux | 3.98B |
Eurofins Scientific SE | 6.95B |
Ipsen | 3.57B |
Virbac | 1.40B |
emeis Société anonyme | 5.43B |